Skip to main content
SpringerLink
Log in

Sehstörungen

  • Chapter
Medikamentös induzierte neurologische und psychiatrische Störungen

  • 784 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 19.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 37.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Allibhai ZA, Gale JS, Sheidow TS (2004) Central serous chorioretinopathy in a patient taking sildenafil citrate. Ophthalmic Surg Lasers Imaging 35: 165–167

    PubMed  Google Scholar 

  • Araiza-Casillas R, Cardenas F, Morales Y, Cardiel MH (2004) Factors associated with chloroquine-induced retinopathy in rheumatic disease. Lupus 13: 119–124

    Article  PubMed  CAS  Google Scholar 

  • Arndt CF, Derambure P, Defoort-Dhellemmes S, Hache JC (1999) Outer retinal dysfunction in patients treated with vigabatrin. Neurology 52: 1201–1205

    PubMed  CAS  Google Scholar 

  • Barron GJ, Tepper L, Irvine G (1974) Ocular toxicity from ethambutol. Am J Ophthalmol 77: 256

    PubMed  CAS  Google Scholar 

  • Becher R, Schutt P, Osieka R, Schmidt CG (1980) Peripheral neuropathy and ophthalmologic toxicity after treatment with cis-dichlorodiaminoplatinum II. J Cancer Res Clin Oncol 96:219–222

    Article  PubMed  CAS  Google Scholar 

  • Bene C, Manzler A, Bene D, Kranias G (1989) Irreversible ocular toxicity from single “chal-lenge” dose of deferoxamine. Clin Nephrol 31: 45–48

    PubMed  CAS  Google Scholar 

  • Bernstein HN (1983) Ophthalmologic considerations and testing in patients receiving long-term antimalaria therapy. Am J Med 75: 25–34

    Article  PubMed  CAS  Google Scholar 

  • Boulanouar A, Abdallah E, Bakkali M el, Benchrifa F, Berraho-Hamani A (1995) Severe toxic optic neuropathies caused by isoniazid. Apropos of 3 cases. J Fr Ophthalmol 18:183–187

    CAS  Google Scholar 

  • Brinkley JR, Dubois EL, Ryan SJ (1979) Long-term course of chloroquine retinopathy after cessation of medication. Am J Ophthalmol 88: 1–11

    PubMed  Google Scholar 

  • Calvo FA, Dy C, Henriquez I, Hidalgo V, Bilbao I, Santos M (1989) Postoperative radical radiotherapy with concurrent weekly intra-arterial cis-platinum for treatment of malignant glioma: a pliot study. Radiother Oncol 14: 83–88

    Article  PubMed  CAS  Google Scholar 

  • Caraceni A, Martini C, Spatti G, Thomas A, Onofrj M (1997) Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy. Acta Neurol Scand 96: 260–261

    PubMed  CAS  Google Scholar 

  • Cases A, Kelly J, Sabater J et al. (1988) Acute visual and auditory neurotoxicity in patients with end-stage renal disease receiving desferrioxamine. Clin Nephrol 29: 176–178

    PubMed  CAS  Google Scholar 

  • Chang N, Giles CL, Gregg RH (1966) Optic neuritis and chloramphenicol. Am J Dis Child 112:46–48

    PubMed  CAS  Google Scholar 

  • Chang T, Gonder JR, Ventresca MR (1992) Low-dose tamoxifen retinopathy. Can J Ophthalmol 27: 148–149

    PubMed  CAS  Google Scholar 

  • Chuenkongkaew W, Samsen R Thanasombatsakul N (2003) Ethambutol and optic neuropathy. J Med Assoc Thai 86: 622–625

    PubMed  CAS  Google Scholar 

  • Citron KM (1969) Ethambutol: a review with special reference to ocular toxicity. Tubercle 50:32

    Article  PubMed  Google Scholar 

  • Cocke JG (1967) Chloramphenicol optic neuritis. Apparent protective effects of very high daily doses of pyridoxine and cyanocobalamin. Am J Dis Child 114: 424–426

    PubMed  Google Scholar 

  • Costa RH, Dhooge MR, Van Wing F, De Rouck AF (1990) Tamoxifen retinopathy. A case report. Bull soc Beige Ophthalml 238: 161–168

    CAS  Google Scholar 

  • Cunningham AV, Smith KH (2001) Anterior ischemic optic neuropathy associated with via-gra. J Neuro-Ophthalmol 21: 22–25

    Article  CAS  Google Scholar 

  • Davies SC, Marcus RE, Hungerford JL, Miller MH, Arden GB, Huehns ER (1983) Ocular toxicity of high-dose intravenous desferrioxamine. Lancet 2: 181–184

    Article  PubMed  CAS  Google Scholar 

  • DePalma P, Franco F, Bragliani G, Michetti L, Marescotti A, Pirazzoli G, Fiorenza M (1989) The incidence of optic neuropathy in 84 patients treated with ethambutol. Metab Pediatr Syst Ophthalmol 12: 80–82

    CAS  Google Scholar 

  • Dette TM, Spitznas M, Gobbels M, Koch F, Leinhos C (1991) Visually evoked cortical potentials for early detection of optic neuritis in ethambutol therapy. Fortschr Ophthalmol 88: 546–548

    PubMed  CAS  Google Scholar 

  • Duboc A, Hanoteau N, Simonutti M, Rudolf G, Nehlig A, Sahel JA, Picaud S (2004) Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats. Ann Neurol 55: 695–705

    Article  PubMed  CAS  Google Scholar 

  • Engelke M, Tykhonova S, Zom-Kruppa M, Diehl H (2002) Tamoxifen induces changes in the lipid composition of the retinal pigment epithelium cell line D407. Pharmacol Toxicol 91: 13–21

    Article  PubMed  CAS  Google Scholar 

  • Farel C, Suzman DL, McLaughlin M et al. (2004) Serious ophthalmic pathology compromising vision in HCV/HIV co-infected patients treated with peginterferon alpha-b and ribavirin. AIDS 18: 1805–1809

    Article  PubMed  CAS  Google Scholar 

  • Feiner LA, Younge BR, Kazmier FJ, Strieker BH, Fraunfelder FT (1987) Optic neuropathy and amiodarone therapy. Mayo Clin Proc 62: 702–717

    PubMed  CAS  Google Scholar 

  • Feun LG, Wallace S, Stewart DJ et al. (1984) Intracarotid infusion of cis-diaminedichloro-platinum in the treatment of recurrent malignant brain tumors. Cancer 54: 794–799

    Article  PubMed  CAS  Google Scholar 

  • Fink HA, MacDonald R, Rutks IR, Nelson DB, Wilt TJ (2002) Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med 162: 1349–1360

    Article  PubMed  CAS  Google Scholar 

  • Flaxel CJ, Mulholland B, Haynes B, Gregor ZJ (2000) Intraocular penetration of tamoxifen. Ophthalmology 107: 2006–2009

    Article  PubMed  CAS  Google Scholar 

  • Freedman MH, Boyden M, Taylor M, Skarf B (1988) Neurotoxicity associated with deferoxamine therapy. Toxicology 49: 283–290

    Article  PubMed  CAS  Google Scholar 

  • Frisch IB, Kunze AK, Castro A, Krastel H, Meinck H-M (2003) Schwerwiegender Verlauf und belastende Faktoren bei Optikusneuropathie und Myelopathie durch Tuberkulostatika. Ophthalmologe 100: 967–970

    Article  PubMed  CAS  Google Scholar 

  • Garcia Rodriguez LA, Mannino S, Wallander MA, Lindblom B (1996) A cohort study of the ocular safety of anti-ulcer drugs. Br J Clin Pharmacol 42: 213–216

    Article  PubMed  CAS  Google Scholar 

  • Gobbele R, Dahlke C, Mull M, Schwarz M (1999) Amiodaron-induzierte bilaterale Optikusneuropathie. Nervenarzt 70: 560–565

    Article  PubMed  CAS  Google Scholar 

  • Godel V, Nemet P, Lazar M (1980) Chloramphenicol optic neuropathy. Arch Ophthalmol 98: 1417–1421

    PubMed  CAS  Google Scholar 

  • Gonzalez CM, Bervig T, Podlasek C, Huang CF, McKenna KE, McVary KT (1999) Sildenafil causes a dose-and time-dependent downregulation of phosphodiesterase type 6 expression in the rat retina. Int J Impot Res 11(suppl 1): 9–14

    Article  Google Scholar 

  • Govier F, Potempa AJ, Kaufman J, Denne J, Kovalenko P, Ahuja S (2003) A multicenter, randomized, double-blind, crossover study of patient preference for tadalafil 20 mg or sidenafil citrate 50 mg during initiation of treatment for erectile dysfunction. Clin Ther 25:2709–2723

    Article  PubMed  CAS  Google Scholar 

  • Haimovici R, D’Amico DJ, Gragoudas ES, Sokol S, Deferoxamine Retinopathy Study Group (2002) The expanded clinical spectrum of deferoxamine retinopathy. Ophthalmology 109: 164–171

    Article  PubMed  Google Scholar 

  • Heier JS, Dragoo RA, Enzenauer RW, Waterhouse WJ (1994) Screening for ocular toxicity in asymptomatic patients treated with tamoxifen. Am J Ophthalmol 117: 772–775

    PubMed  CAS  Google Scholar 

  • Hejny C, Sternberg P, Lawson DH, Greiner K, Aaberg TM (2001) Retinopathy associated with high-dose interferon alfa-2b therapy. Am J Ophthalmol 131: 782–787

    Article  PubMed  CAS  Google Scholar 

  • Johnson MA, Krauss GL, Miller NR, Medura M, Paul SR (2000) Visual loss from vigabatrin. Effect of stopping the drug. Neurology 55: 40–45

    PubMed  CAS  Google Scholar 

  • Kadayifcilar S, Boyacioglu S, Kart H, Gursoy M, Aydin P (1999) Ocular complications with high-dose interferon alpha in chronic active hepatitis. Eye 13: 241–246

    PubMed  Google Scholar 

  • Kaiser-Kupfer MI, Lippman ME (1978) Tamoxifen retinopathy. Cancer Treat Rep 62: 315–320

    PubMed  CAS  Google Scholar 

  • Kaiser-Kupfer MI, Kupfer C, Rodrigues MM (1981) Tamoxifen retinopathy. A cliniopatholo-gic report. Ophthalmology 88: 89–93

    PubMed  CAS  Google Scholar 

  • Kälviäinen R, Nouisainen I, Mäntyjärvi M, Nikoskelainen E, Partanen J, Partanen K, Riekkinen P (1999) Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects. Neurology 53: 922–926

    PubMed  Google Scholar 

  • Karmon G, Savir H, Zevin D, Levi J (1979) Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment. Ann Ophthalmol 11: 1013–1017

    PubMed  CAS  Google Scholar 

  • Karnik AM, Al-Shamali MA, Fenech FF (1985) A case of ocular toxicity to ethambutol — an idiosyncratic reaction? Postgrad Med J 61: 811–813

    PubMed  CAS  Google Scholar 

  • Katz BJ, Ward JH, Digre KB, Creel DJ, Mamalis N (2003) Persistent severe visual and electroretinographic abnormalities after intravenous cisplatin therapy. J Neuroophthalmol 23: 132–135

    PubMed  Google Scholar 

  • Kawano T, Shigehira M, Uto H et al. (1996) Retinal complications during interferon therapy for chronic hepatitis C. Am J Gastroenterol 91: 309–313

    PubMed  CAS  Google Scholar 

  • Khawly JA, Rubin P, Petros W, Peters WP, Jaffe GJ (1996) Retinopathy and optic neuropathy in bone marrow transplantation for breast cancer. Ophthalmology 103: 87–95

    PubMed  CAS  Google Scholar 

  • Kiyosawa M, Ishikawa S (1981) A case of isoniazid optic neuropathy. Neuro-Ophthalmology 2: 67

    Article  Google Scholar 

  • Kohno M, Yamada M, Okumura T, Hori K, Hoshino U, Yoshimura T (2000) Two cases of ocular damage associated with proton pump inhibitors. Nippon Shokakibyo Gakkai Zasshi 97: 575–579

    PubMed  CAS  Google Scholar 

  • Krauss GL, Johnson MA, Sheth S, Miller NR (2003) A controlled study comparing visual function in patients treated with vigabatrin and tiagabine. J Neurol Neurosur Ps 74: 3392–343

    Google Scholar 

  • Krieg P, Schipper I (1992) Bilaterale Optikusneuropathie nach Amiodaron-Therapie. Klin Monatsbl Augenheilk 200: 1282–132

    Google Scholar 

  • Kumar A, Sandramouli S, Verma L, Tewari HK, Khosla PK (1993) Ocular ethambutol toxicity: is it reversible? J Clin Neuroophthalmol 13: 15–17

    PubMed  CAS  Google Scholar 

  • Lakhanpal V, Schocket SS, Jiji R (1984) Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy. Ophthalmology 91:443–451

    PubMed  CAS  Google Scholar 

  • Lamba PA, Sood NN, Moorthy SS (1968) Retinopathy due to chloramphenicol. Scott Med J 13: 166–169

    PubMed  CAS  Google Scholar 

  • Lawden MC, Eke T, Degg C, Harding GFA, Wild JM (1999) Visual field defects associated with vigabatrin therapy. J Neurol Neurosur Ps 67: 716–722

    CAS  Google Scholar 

  • Leppert D, Waespe W (1988) Neurotoxicity of antituberculous drugs in a patient without active tuberculosis. Ital J Neurol Sci 9: 31–34

    Article  PubMed  CAS  Google Scholar 

  • Lindquist M, Petterson M, Edwards IR et al. (1996) Omeprazol and visual disorders: seeing alternatives. Pharmacoepidemiol Drug Saf 5: 27–32

    Article  PubMed  CAS  Google Scholar 

  • Lockman P, Shum O (1998) Optic neuritis in acute isoniazid overdose. J Toxicol Clin Toxicol 36: 475

    Google Scholar 

  • Lutz M, Schwab M, Griese EU et al. (2002) Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism. Pharmacogenetics 12: 73–75

    Article  PubMed  CAS  Google Scholar 

  • Luu JK, Chappelow AV, McCulley TJ, Marmor MF (2001) Acute effects of sildenafil on the electroretinogram and multifocal electroretinogram. Am J Ophthalmol 132:388–394

    Article  PubMed  CAS  Google Scholar 

  • Macaluso DC, Shults WT, Fraunfelder FT (1999) Features of amiodaron-induced optic neuropathy. Am J Ophthalmol 127: 610–612

    Article  PubMed  CAS  Google Scholar 

  • Mackenzie AH (1983) Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials. Am J Med 75: 40–45

    Article  PubMed  CAS  Google Scholar 

  • Manesis EK, Petrou C, Brouzas D, Hadziyannis S (1994) Optic tract neuropathy complicating low-dose interferon treatment. J Hepatol 21: 474–477

    Article  PubMed  CAS  Google Scholar 

  • Manesis EK, Moschos M, Brouzas D, Kotsiras J, Petrou C, Theodosiadis G, Hadziyannis S (1998) Neurovisual impairment: a frequent complication of alpha-interferon treatment in chronic viral hepatitis. Hepatology 27: 421–1427

    Article  Google Scholar 

  • Mannino S, Troncon MG, Wallander MA et al. (1998) Ocular disorders in users of H2 antagonists and of omeprazole. Pharmacoepidemiol Drug Saf 7: 233–241

    Article  PubMed  CAS  Google Scholar 

  • Mansfield SH, Castillo M (1994) MR of cis-platinum-induced optic neuritis. AJNR Am J Neuroradiol 15: 1178–1180

    PubMed  CAS  Google Scholar 

  • Mansour AM, Puklin JE, O’Grady R (1988) Optic nerve ultrastructure following amiodarone therapy. J Clin Neuroophthalmol 8: 231–237

    PubMed  CAS  Google Scholar 

  • Marmor MF (1993) Negative-type electroretinogram from cisplatin toxicity. Doc Ophthalmol 84: 237–246

    Article  PubMed  CAS  Google Scholar 

  • Matsuo T, Takakbatake R (2002) Multiple sclerosis-like disease to alpha interferon. Ocul Immunol Inflamm 10: 299–304

    Article  PubMed  Google Scholar 

  • Mavrikakis M, Papazoglou S, Sfikakis PP, Vaiopoulos G, Rougas K (1996) Retinal toxicity in long term hydroxychloroquine treatment. Ann Rheum Dis 55: 187–189

    Article  PubMed  CAS  Google Scholar 

  • Mavrikakis I, Sfikakis PP, Mavrikakis E, Rougas K, Nikolaou A, Kostopoulos C, Mavrikakis M (2003) The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal. Ophthalmology 110: 1321–1326

    Article  PubMed  Google Scholar 

  • McCulley TJ, Luu JK, Marmor MF, Feuer WJ (2002) Effects of sildenafil citrate (Viagra) on choroidal congestion. Ophthalmologica 216: 455–458

    Article  PubMed  CAS  Google Scholar 

  • McDonagh J, Stephen LJ, Dolan FM et al. (2003) Peripheral retinal dysfunction in patients taking vigabatrin. Neurology 61: 1690–1694

    PubMed  CAS  Google Scholar 

  • McKeown CA, Swartz M, Blom J, Maggiano JM (1981) Tamoxifen retinopathy. Br J Ophthalmol 65: 177–179

    Article  PubMed  CAS  Google Scholar 

  • McMahon CG (2002) High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction. Int J Impot Res 14: 533–538

    Article  PubMed  CAS  Google Scholar 

  • Melamud A, Kosmorsky GS, Lee MS (2003) Ocular ethambutol toxicity. Mayo Clin Proc 78: 1409–1411

    Article  PubMed  Google Scholar 

  • Miller DF, Bay JW, Lederman RJ, Purvis JD, Rogers LR, Tomsak RL (1985) Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas. Ophthalmology 92: 402–406

    PubMed  CAS  Google Scholar 

  • Moschos M, Manesis E, Panagakis E, Brouzas D, Hadziyannis S, Theodossiadis G (1997) The effect of low-dose interferon treatment on visual evoked potentials. Doc Ophthalmol 94:215–221

    Article  PubMed  Google Scholar 

  • Munier F, Uffer S, Herbort CP et al. (1992) Loss of ganglion cells in the retina secondary to vincristine therapy. Klin Monatsbl Augenheilkd 200: 550–554

    Article  PubMed  CAS  Google Scholar 

  • Nagra PK, Foroozan R, Savino PJ, Castillo I, Sergott RC (2003) Amiodarone induced optic neuropathy. Br J Ophthalmol. 87: 420–422

    Article  PubMed  CAS  Google Scholar 

  • Neubauer AS, Samari-Kermani K, Schaller U, Welge-LuBen U, Rudolph G, Beminger T (2003) Detecting chloroquine retinopathy: electro-oculogram versus colour vision. Br J Ophthalmol 87: 902–908

    Article  PubMed  CAS  Google Scholar 

  • Norton SW, Stockman JA (1979) Unilateral optic neuropathy following vincristine chemotherapy. J Pediatr Ophthalmol Strabismus 16: 190–193

    PubMed  CAS  Google Scholar 

  • Noureddin BN, Seoud M, Bashshur Z, Salem Z, Shamseddin A, Khalil A (1999) Ocular toxicity in low-dose tamoxifen: a prospective study. Eye 13: 729–733

    PubMed  Google Scholar 

  • Nousiainen I, Mäntyjärvi M, Kälviäinen R (2001) No reversion in vigabatrin-associated visual field defects. Neurology 57: 1916–1917

    PubMed  CAS  Google Scholar 

  • Olivieri NF, Buncic JR, Chew E et al. (1986) Visual and auditory neurotoxicity in patients receiving subcutaneous deferoxamine infusions. N Engl J Med 314: 869–873

    Article  PubMed  CAS  Google Scholar 

  • Orton RB, DeVeber LL, Sulh HM (1985) Ocular and auditory toxicity of long-term, high-dose subcutaneous deferoxamine therapy. Can J Ophthalmol 20: 153–156

    PubMed  CAS  Google Scholar 

  • Ostrow S, Hahn D, Wiernik PH, Richards RD (1978) Ophthalmologic toxicity after cis-dichlorodiammineplatinum (II) therapy. Cancer Treat Rep 62: 1591–1594

    PubMed  CAS  Google Scholar 

  • Parkkari M, Paakkala AM, Salminen L, Holli K (2003) Ocular side-effects in breast cancer patients treated with tamoxifen and toremifene: a randomized follow-up. Acta Ophthalmol Scand 81: 495–499

    Article  PubMed  CAS  Google Scholar 

  • Pavlidis NA, Petris C, Briassoulis E, Klouvas G, Psilas C, Rempapis J, Petroutsos G (1992) Clear evidence that long-term, low-dose tamoxifen treatment can induce ocular toxicity. A prospective study of 63 patients. Cancer 69: 2961–2964

    Article  PubMed  CAS  Google Scholar 

  • Pomeranz HD, Smith KH, Hart WM, Egan RA (2002) Sildenafil-associated nonarteritic ischemic optic neuropathy. Ophthalmology 109: 584–587

    Article  PubMed  Google Scholar 

  • Purvin VA (1995) Anterior ischemic optic neuropathy secondary to interferon alfa. Arch Ophthalmol 113: 1041–1044

    PubMed  CAS  Google Scholar 

  • Rahi AH, Hungerford JL, Ahmed AI (1986) Ocular toxicity of desferrioxamine: light microscopic histochemical and ultrastructural findings. Br J Ophthalmol 70: 373–381

    Article  PubMed  CAS  Google Scholar 

  • Ramilo O, Kinane BT, McCracken GH (1988) Chloramphenicol neurotoxicity. Pediatr Infect Dis J 7: 358–359

    Article  PubMed  CAS  Google Scholar 

  • Rothkoff L, Biedner B, Shoham K, Blumenthal M (1979) Optic atrophy after irrigation of the lacrimal ducts with chloramphenicol. Ann Ophthalmol 11: 105–106

    PubMed  CAS  Google Scholar 

  • Sanderson PA, Kuwabara T, Cogan DG (1976) Optic neuropathy presumably caused by vincristine therapy. Am J Ophthalmol 81: 146–150

    PubMed  CAS  Google Scholar 

  • Santoro L, Barbieri F, Nuccioti R et al. (1992) Amiodarone-induced experimental acute neuropathy in rats. Muscle Nerve 15: 788–795

    Article  PubMed  CAS  Google Scholar 

  • Schmidt D (2003) Amiodarone treatment and visual prognosis. Klin Monatsbl Augenheilk 220: 774–786

    Article  Google Scholar 

  • Schmidt T, Rüther K, Jokiel B, Pfeiffer S, Tiel-Wilck K, Schmitz B (2002) Is visual field constriction in epilepsy patients treated with vigabatrin reversible? J Neurol 249: 1066–1071

    Article  PubMed  CAS  Google Scholar 

  • Schönhofer PS, Werner B, Troger U (1997) Ocular damage associated with proton pump inhibitors. BMJ 314: 1805

    PubMed  Google Scholar 

  • Schulman JA, Liang C, Kooragayala LM, King J (2003) Posterior segment complications in patients with hepatitis C treated with interferon and ribavirin. Ophthalmology 110: 437–442

    Article  PubMed  Google Scholar 

  • Shimamura Y, Chikama M, Tanimoto T, Kawakami Y, Tsutsumi A (1990) Optic nerve degeneration caused by supraophthalmic carotid artery infusion with cisplatin and ACNU. Case Report. J Neurosurg 72: 285–288

    PubMed  CAS  Google Scholar 

  • Shurin SB, Rekate HL, Annable W (1982) Optic atrophy induced by vincristine. Pediatrics 70: 288–291

    PubMed  CAS  Google Scholar 

  • Sivakumaran P, Harrison AC, Marschner J, Martin P (1998) Ocular toxicity from ethambutol: a review of four cases and recommended precautions. N Z Med J 111: 428–430

    PubMed  CAS  Google Scholar 

  • Sreih AG, Schoenfeld MH, Marieb MA (1999) Optic neuropathy following amiodarone therapy. Pacing Clin Electrophysiol 22: 1108–1110

    Article  PubMed  CAS  Google Scholar 

  • Srivastava AK, Goel UC, Bajaj S, Singh KJ, Dwivedi NC, Tandon MP (1997) Visual evoked responses in ethambutol induced optic neuritis. Assoc Physicians India 45: 847–849

    CAS  Google Scholar 

  • Stewart DJ, Grahovac Z, Hugenholtz H et al. (1993) Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors. J Neurooncol 17: 71–79

    Article  PubMed  CAS  Google Scholar 

  • Sugano S, Suzuki T, Watanabe M, Ohe K, Ishii K, Okajima T (1998) Retinal complications and plasma C5a levels during interferon alpha therapy for chronic hepatitis C. Am J Gastroenterol 93: 2441–2444

    Article  PubMed  CAS  Google Scholar 

  • Szwarcberg J, Mack G, Flament J (2002) Ocular toxicity of deferoxamine: description and analysis of three observations. J Fr Ophthalmol 25: 609–614

    CAS  Google Scholar 

  • Tang R, Shields J, Schiffman J, Li H, Locher D, Hampton J, Prager T, Pardo G (1997) Retinal changes associated with tamoxifen treatment for breast cancer. Eye 11: 295–297

    PubMed  Google Scholar 

  • Taylor MJ, Keenan NK, Gallant T, Skarf B, Freedman MH, Logan WJ (1987) Subclinical VEP abnormalities in patients on chronic deferoxamine therapy: longitudinal studies. Electroencephalogr Clin Neurophysiol 68: 81–87

    Article  PubMed  CAS  Google Scholar 

  • Teichmann KD, Dabbagh N (1988) Severe visual loss after single dose of vincristine in a patient with spinal cord astrocytoma. J Ocul Pharmacol 4: 117–121

    Article  PubMed  CAS  Google Scholar 

  • Therssen R, Jansen E, Leys A, Rutten J, Meyskens J (1995) Screening for tamoxifen ocular toxicity: a prospective study. Eur J Ophthalmol 5: 230–234

    PubMed  CAS  Google Scholar 

  • Tzekov RT, Serrato A, Marmor MF (2004) ERG findings in patients using hydroxychloroquine. Doc Ophthalmol 108: 87–97

    Article  PubMed  Google Scholar 

  • Urba S, Forastiere AA (1988) Retrobulbar neuritis in a patient treated with intraarterial cisplatin for head and neck cancer. Cancer 62: 2094–2097

    Article  PubMed  CAS  Google Scholar 

  • Vardizer Y, Linhart Y, Loewenstein A, Garzozi H, Mazawi N, Kesler A (2003) Interferon-alpha-associated bilateral ischemic optic neuropathy. J Neuroophthalmol 23: 256–259

    PubMed  Google Scholar 

  • Vinding T, Nielsen NV (1983) Retinopathy caused treatment with tamoxifen in low dosage. Acta Ophthalmol 61: 45–50

    CAS  Google Scholar 

  • Vu BL, Easterbrook M, Hovis JK (1999) Detection of color vision defects in chloroquine retinopathy. Ophthalmology 106: 1799–1803

    Article  PubMed  CAS  Google Scholar 

  • Wang MY, Arnold AC, Vinters HV, Glasgow BJ (2000) Bilateral blindness and lumbosacral myleopathy assocaited with high-dose carmustine and cisplatin therapy. Am J Ophthalmol 130:367–368

    Article  PubMed  CAS  Google Scholar 

  • Wilding G, Caruso R, Lawrence TS, Ostchega Y, Ballintine EJ, Young RC, Ozols RF (1985) Retinal toxicity after high-dose cisplatin therapy. J Clin Oncol 3: 1683–1689

    PubMed  CAS  Google Scholar 

  • Wilton LV, Stephens MD, Mann RD (1999) Interim report on the incidence of visual field defects in patients on long term vigabatrin therapy. Pharmacoepidemiol Drug Saf 8(suppl 1): 9–14

    Article  Google Scholar 

  • Woung LC, Jou JR, Liaw SL (1995) Visual function in recovered ethambutol optic neuropathy. J Ocul Pharmacol Ther 11: 411–419

    Article  PubMed  CAS  Google Scholar 

  • Wu HM, Lee AG, Lehane DE, Chi TL, Lewis RA (1997) Ocular and orbital complications on intraarterial cisplatin. A case report. J Neuroophthalmol 17: 195–198

    PubMed  CAS  Google Scholar 

  • Yanyali AC, Freund KB, Sorenson JA, Slakter JS, Wheatley HM (2001) Tamoxifen retinopathy in a male patient. Am J Ophthalmol 131: 386–387

    Article  PubMed  CAS  Google Scholar 

  • Zoumalan Cl, Agarwal M, Sadun AA (2005) Optical coherence tomography can measure axonal loss in patients with ethambutol-induced optic neuropathy. Graefes Arch Clin Exp Ophthalmol 243(5): 410–416

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Klinik Helios-Kliniken Schwerin, Wismarsche Str. 393-397, 19049, Schwerin

    Prof. Dr. med. F. Block

Authors
  1. Prof. Dr. med. F. Block
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Neurologische Klinik, Helios-Kliniken Schwerin, Wismarsche Straße 392-397, 19049, Schwerin

    Frank Block

  2. Gangelter Einrichtungen Krankenhaus Maria Hilf, Fachkrankenhaus für Psychiatrie und Psychotherapie, Brunchstraße 6, 52538, Gangelt

    Christian Prüter

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Block, F. (2006). Sehstörungen. In: Block, F., Prüter, C. (eds) Medikamentös induzierte neurologische und psychiatrische Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-28604-7_15

Download citation

  • DOI: https://doi.org/10.1007/3-540-28604-7_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-28590-8

  • Online ISBN: 978-3-540-28604-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation